Elevated Alpha Fetoprotein, No Hepatocellular Carcinoma

Journal of Clinical and Experimental Hepatology

Volumn 3, Issue 2, 2013, Pages 162-164

  Patil, Mallikarjun ^a   Sheth, Keyur A ^a   Adarsh, Channagiri K ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Alpha fetoprotein (AFP); Hepatitis B infection; Hepatocellular carcinoma (HCC)

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE PLUS TENOFOVIR DISOPROXIL; VIRUS DNA;

ADULT; ANOREXIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; EYE JAUNDICE; HEPATITIS B; HEPATOMEGALY; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; LIVER CELL CARCINOMA; MALE; MEDICATION COMPLIANCE; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 84879782000     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2013.02.246     Document Type: Article

References (8)

1. Sangiovanni A., Prati G.M., Fasani P., et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 2006, 43:1303-1310.
2. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. JHepatol 2012, 56(4):908-943.
3. Gupta S., Bent S., Kohlwes J. Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 2003, 139(1):46-50.
4. Soresi M., Magliarisi C., Campagna P., et al. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res 2003, 23(2C):1747-1753.
5. Daniele B., Bencivenga A., Megna A.S., Tinessa V. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 2004 Nov, 127(5 suppl 1):S108-S112.
6. Zhou L., Liu J., Luo F. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006 Feb 28, 12(8):1175-1181.
7. Yao F.Y. Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis. JClin Gastroenterol 2003, 36(5):440-442.
8. Bae J.S., Park S.J., Park K.B., et al. Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma. Korean J Intern Med 2005, 20(1):80-85.